Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

Sander Kelderman; Bianca Heemskerk; Harm van Tinteren; Rob R. H. van den Brom; Geke A. P. Hospers; Alfonsus J. M. van den Eertwegh; Ellen W. Kapiteijn; Jan Willem B. de Groot; Patricia Soetekouw; Rob L. Jansen; Edward Fiets; Andrew J. S. Furness; Alexandra Renn; Marcin Krzystanek; Zoltan Szallasi; Paul Lorigan; Martin E. Gore; Ton N. M. Schumacher; John B. A. G. Haanen; James M. G. Larkin; Christian U. Blank

doi:10.1007/s00262-014-1528-9

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

Sander Kelderman, Bianca Heemskerk, Harm van Tinteren, Rob R. H. van den Brom, Geke A. P. Hospers, Alfonsus J. M. van den Eertwegh, Ellen W. Kapiteijn, Jan Willem B. de Groot, Patricia Soetekouw, Rob L. Jansen, Edward Fiets, Andrew J. S. Furness, Alexandra Renn, Marcin Krzystanek, Zoltan Szallasi, Paul Lorigan, Martin E. Gore, Ton N. M. Schumacher, John B. A. G. Haanen, James M. G. LarkinChristian U. Blank^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	449-458
Journal	Cancer Immunology Immunotherapy
Volume	63
Issue number	5
DOIs	https://doi.org/10.1007/s00262-014-1528-9
Publication status	Published - May 2014

Keywords

Melanoma
Immunotherapy
Ipilimumab
Lactate dehydrogenase
Biomarker

Access to Document

10.1007/s00262-014-1528-9

Cite this

Kelderman, S., Heemskerk, B., van Tinteren, H., van den Brom, R. R. H., Hospers, G. A. P., van den Eertwegh, A. J. M., Kapiteijn, E. W., de Groot, J. W. B., Soetekouw, P., Jansen, R. L., Fiets, E., Furness, A. J. S., Renn, A., Krzystanek, M., Szallasi, Z., Lorigan, P., Gore, M. E., Schumacher, T. N. M., Haanen, J. B. A. G., ... Blank, C. U. (2014). Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. Cancer Immunology Immunotherapy, 63(5), 449-458. https://doi.org/10.1007/s00262-014-1528-9

Kelderman, Sander ; Heemskerk, Bianca ; van Tinteren, Harm ; van den Brom, Rob R. H. ; Hospers, Geke A. P. ; van den Eertwegh, Alfonsus J. M. ; Kapiteijn, Ellen W. ; de Groot, Jan Willem B. ; Soetekouw, Patricia ; Jansen, Rob L. ; Fiets, Edward ; Furness, Andrew J. S. ; Renn, Alexandra ; Krzystanek, Marcin ; Szallasi, Zoltan ; Lorigan, Paul ; Gore, Martin E. ; Schumacher, Ton N. M. ; Haanen, John B. A. G. ; Larkin, James M. G. ; Blank, Christian U. / Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. In: Cancer Immunology Immunotherapy. 2014 ; Vol. 63, No. 5. pp. 449-458.

@article{032ab4f4d49e4232b80147ce7c45914a,

title = "Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma",

keywords = "Melanoma, Immunotherapy, Ipilimumab, Lactate dehydrogenase, Biomarker",

author = "Sander Kelderman and Bianca Heemskerk and {van Tinteren}, Harm and {van den Brom}, {Rob R. H.} and Hospers, {Geke A. P.} and {van den Eertwegh}, {Alfonsus J. M.} and Kapiteijn, {Ellen W.} and {de Groot}, {Jan Willem B.} and Patricia Soetekouw and Jansen, {Rob L.} and Edward Fiets and Furness, {Andrew J. S.} and Alexandra Renn and Marcin Krzystanek and Zoltan Szallasi and Paul Lorigan and Gore, {Martin E.} and Schumacher, {Ton N. M.} and Haanen, {John B. A. G.} and Larkin, {James M. G.} and Blank, {Christian U.}",

year = "2014",

month = may,

doi = "10.1007/s00262-014-1528-9",

language = "English",

volume = "63",

pages = "449--458",

journal = "Cancer Immunology Immunotherapy",

issn = "0340-7004",

publisher = "Springer",

number = "5",

}

Kelderman, S, Heemskerk, B, van Tinteren, H, van den Brom, RRH, Hospers, GAP, van den Eertwegh, AJM, Kapiteijn, EW, de Groot, JWB, Soetekouw, P, Jansen, RL, Fiets, E, Furness, AJS, Renn, A, Krzystanek, M, Szallasi, Z, Lorigan, P, Gore, ME, Schumacher, TNM, Haanen, JBAG, Larkin, JMG & Blank, CU 2014, 'Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma', Cancer Immunology Immunotherapy, vol. 63, no. 5, pp. 449-458. https://doi.org/10.1007/s00262-014-1528-9

Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. / Kelderman, Sander; Heemskerk, Bianca; van Tinteren, Harm; van den Brom, Rob R. H.; Hospers, Geke A. P.; van den Eertwegh, Alfonsus J. M.; Kapiteijn, Ellen W.; de Groot, Jan Willem B.; Soetekouw, Patricia; Jansen, Rob L.; Fiets, Edward; Furness, Andrew J. S.; Renn, Alexandra; Krzystanek, Marcin; Szallasi, Zoltan; Lorigan, Paul; Gore, Martin E.; Schumacher, Ton N. M.; Haanen, John B. A. G.; Larkin, James M. G.; Blank, Christian U.

In: Cancer Immunology Immunotherapy, Vol. 63, No. 5, 05.2014, p. 449-458.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma

AU - Kelderman, Sander

AU - Heemskerk, Bianca

AU - van Tinteren, Harm

AU - van den Brom, Rob R. H.

AU - Hospers, Geke A. P.

AU - van den Eertwegh, Alfonsus J. M.

AU - Kapiteijn, Ellen W.

AU - de Groot, Jan Willem B.

AU - Soetekouw, Patricia

AU - Jansen, Rob L.

AU - Fiets, Edward

AU - Furness, Andrew J. S.

AU - Renn, Alexandra

AU - Krzystanek, Marcin

AU - Szallasi, Zoltan

AU - Lorigan, Paul

AU - Gore, Martin E.

AU - Schumacher, Ton N. M.

AU - Haanen, John B. A. G.

AU - Larkin, James M. G.

AU - Blank, Christian U.

PY - 2014/5

Y1 - 2014/5

KW - Melanoma

KW - Immunotherapy

KW - Ipilimumab

KW - Lactate dehydrogenase

KW - Biomarker

U2 - 10.1007/s00262-014-1528-9

DO - 10.1007/s00262-014-1528-9

M3 - Article

C2 - 24609989

VL - 63

SP - 449

EP - 458

JO - Cancer Immunology Immunotherapy

JF - Cancer Immunology Immunotherapy

SN - 0340-7004

IS - 5

ER -